June 20, 2020

Taking Hydroxychloroquine “Just in Case” Could Backfire
Two major developments on the hydroxychloroquine front have changed the picture regarding on taking the drug. As a trusted healthcare professional, pharmacists are well positioned to discuss new evidence that hydroxychloroquine and chloroquine not only do not help patients with COVID-19, they reduce the efficacy of other drugs that do improve outcomes. Read more.


Advertisement

Common Steroid Saving Lives
The very good news: An inexpensive steroid dramatically cut death rates in patients hospitalized with the novel coronavirus—the first drug shown to increase survival. More  good news: Patients who use the anti-inflammatory medication for arthritis, ulcerative colitis, lupus, psoriasis, or breathing disorders are unlikely to have trouble getting it. Find out more about this promising treatment.

Community Pharmacists Need to Report COVID-19 Test Results
The pandemic continues to change the roles and expectations of community pharmacists on a nearly daily basis. With testing now happening in neighborhood pharmacies, the government has issued new guidelines for reporting. Learn more about what’s required and when you need to comply.

 
Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App